Prevalence and Antimicrobial Resistance of Klebsiella pneumoniae Infections in Children: A Ten-year Retrospective Study at a Tertiary Hospital in Guangzhou, China.
Аннотация
PURPOSE: To investigate the clinical distribution and resistance trends of Klebsiella pneumoniae (KP) among pediatric patients at a tertiary pediatric hospital in Guangzhou, China (2015-2024), with a focus on extended-spectrum β-lactamase-producing (ESBL-KP) and carbapenem-resistant (CRKP) strains.
PATIENTS AND
METHODS
A retrospective analysis was performed on non-duplicate KP isolates obtained from pediatric patients (aged ≤14 years) at Guangdong Women and Children Hospital (2015-2024). Time trends of isolated rates and resistance rates for the KP strains were analyzed using Joinpoint regression, with statistical analysis performed in SPSS and Python.
RESULTS
A total of 2907 non-duplicate KP isolates from 2557 patients were analyzed. The proportion of KP among all clinical isolates decreased significantly from 18.4% (492/2670) in 2015 to 6.5% (203/3135) in 2024 (P < 0.05), with the highest proportion (49.0%,1254/2258) observed in infants aged ≤1 month. The KP strains were most often cultured from lower respiratory tract specimens (70.8%, 2059/2907), followed by blood (10.0%, 292/2907) and urine specimens (7.8%, 227/2907). The strains showed two peaks of third- generation cephalosporin resistance in 2018 (64.3% [231/359] for ceftriaxone, 52.1% [215/498] for ceftazidime) and 2023 (42.0% [55/131] for ceftriaxone, 34.1% [45/132] for ceftazidime), and the highest resistance rates of carbapenems were 20.8% (97/466) in 2016. The proportion of ESBL-KP among all KP isolates decreased from 54.3% (266/490) to 29.1% (59/203) (P < 0.05). ESBL-KP isolates were found more frequently in blood and urine. The proportion of CRKP remained stable (7.5% [37/492] to 7.9% [16/203]; P > 0.05). CRKP was mainly found in ICU wards. CRKP rates dropped from 67.6% (25/37) to 0% (0/16) in the neonatal intensive care unit (NICU) but increased from 10.3% (4/39) to 50.0% (8/16) in the pediatric intensive care unit (PICU). Patients infected with ESBL-KP or CRKP were associated with significantly longer hospital stays compared to those caused by non-multidrug-resistant strains (P < 0.05).
CONCLUSION
Despite a decreasing overall prevalence of KP, the persistent high prevalence of ESBL-KP and the rapidly increasing trend of CRKP in the PICU suggested that recalibrated, unit-specific antimicrobial strategies were necessary. This study provides supporting information for the rational use of antimicrobial agents in clinical practice based on the comprehensive investigation of antimicrobial resistance change.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.